Which are the causes of Beckwith-Wiedemann Syndrome?

TL;DR: Beckwith-Wiedemann Syndrome is primarily caused by complex epigenetic or genetic alterations involving the 11p15.5 region of chromosome 11, which controls growth-regulating genes. These disruptions usually occur sporadically during early embryonic development rather than being inherited from parents, leading to the characteristic overgrowth and physical features associated with the condition.

What causes Beckwith-Wiedemann Syndrome?

At its core, Beckwith-Wiedemann Syndrome is a disorder of "genomic imprinting." In a healthy individual, certain genes are expressed differently depending on whether they are inherited from the mother or the father. Think of these genes like a light switch that is meant to be "on" or "off" based on the parent of origin. In Beckwith-Wiedemann Syndrome, these switches are malfunctioning, leading to the over-expression of growth-promoting genes (such as IGF2) or the silencing of growth-suppressing genes (such as CDKN1C).

What are the specific genetic and epigenetic factors involved?

The molecular causes of Beckwith-Wiedemann Syndrome are diverse, which is why the clinical presentation varies so significantly among the 241 members of our DiseaseMaps community. Research has identified four primary mechanisms that account for the majority of cases:

• Loss of Methylation (LOM) at the KCNQ1OT1 domain: Occurs in approximately 50% of cases; the "off" switch for the paternal allele is missing.


• Gain of Methylation (GOM) at the H19/IGF2 domain: Occurs in about 5% of cases; leads to double the amount of the growth factor IGF2.


• Paternal Uniparental Disomy (UPD): Occurs in about 20% of cases; the child inherits two copies of the chromosome 11 region from the father and none from the mother.


• CDKN1C Mutations: Occurs in roughly 5% of cases; these are specific mutations in the growth-suppressor gene.

Is Beckwith-Wiedemann Syndrome hereditary?

For the vast majority of families, Beckwith-Wiedemann Syndrome is a sporadic event, meaning it occurs by chance in a single pregnancy with a very low recurrence risk (less than 1%) for future siblings. However, in a small subset of cases—particularly those involving CDKN1C mutations or certain chromosomal rearrangements—the condition can be inherited in an autosomal dominant pattern. Because inheritance patterns are complex, clinical genetic counseling is essential for families planning future pregnancies.

Are there environmental or external triggers?

There is no evidence that Beckwith-Wiedemann Syndrome is caused by anything the parents did or did not do during pregnancy. While there has been ongoing research into whether Assisted Reproductive Technologies (ART), such as IVF, slightly increase the risk of imprinting disorders, the absolute risk remains very low. Currently, the medical community views Beckwith-Wiedemann Syndrome as a developmental error that occurs during the very early stages of cell division, rather than a result of environmental exposures or toxins.

How is research advancing our understanding of the etiology?

While the genetic basis of Beckwith-Wiedemann Syndrome is well-mapped, researchers are currently focusing on "mosaicism." This refers to the fact that some patients have the genetic alteration in only a portion of their cells, while others have it in all cells. This explains why some individuals have mild symptoms while others have more severe manifestations. Ongoing studies are also investigating how these epigenetic changes influence tumor risk, which helps clinicians create better surveillance protocols for children with the syndrome.

Next steps

• Consult with a board-certified clinical geneticist to confirm the specific molecular subtype of the condition.


• Speak with a pediatric oncologist or endocrinologist to establish a tailored tumor surveillance schedule.


• Connect with the 241 members of our DiseaseMaps community to share experiences and coping strategies.


• Visit the NIH GARD website to stay updated on the latest clinical trial developments.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Beckwith-Wiedemann Syndrome.


• Orphanet: The portal for rare diseases and orphan drugs (ORPHA:107).


• OMIM (Online Mendelian Inheritance in Man): Entry #130650.


• The Beckwith-Wiedemann Children’s Foundation International.